Drug Profile
ETX 9101
Alternative Names: ETX9101; Orovair; SyncovairLatest Information Update: 03 Oct 2015
Price :
$50
*
At a glance
- Originator e-Therapeutics
- Class Antiasthmatics
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Asthma